These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32513829)

  • 1. Differential Coassembly of α1-GABA
    Hannan S; Affandi AHB; Minere M; Jones C; Goh P; Warnes G; Popp B; Trollmann R; Nizetic D; Smart TG
    J Neurosci; 2020 Jul; 40(29):5518-5530. PubMed ID: 32513829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory synapse deficits caused by familial α1 GABA
    Chen X; Durisic N; Lynch JW; Keramidas A
    Neurobiol Dis; 2017 Dec; 108():213-224. PubMed ID: 28870844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered thalamic GABAA-receptor subunit expression in the stargazer mouse model of absence epilepsy.
    Seo S; Leitch B
    Epilepsia; 2014 Feb; 55(2):224-32. PubMed ID: 24417662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA
    Hannan S; Minere M; Harris J; Izquierdo P; Thomas P; Tench B; Smart TG
    Neuropharmacology; 2020 Jun; 169():107540. PubMed ID: 30794836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The de novo missense mutation F224S in GABRB2, identified in epileptic encephalopathy and developmental delay, impairs GABA
    Li PP; Zhou YY; Gao L; Lv JN; Xu SS; Zhao YW; Xu D; Huang R; Zhang X; Li P; Fu X; He Z
    Neuroscience; 2024 Aug; 553():172-184. PubMed ID: 38964454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies.
    Hernandez CC; XiangWei W; Hu N; Shen D; Shen W; Lagrange AH; Zhang Y; Dai L; Ding C; Sun Z; Hu J; Zhu H; Jiang Y; Macdonald RL
    Brain; 2019 Jul; 142(7):1938-1954. PubMed ID: 31056671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAHA (Vorinostat) Corrects Inhibitory Synaptic Deficits Caused by Missense Epilepsy Mutations to the GABA
    Durisic N; Keramidas A; Dixon CL; Lynch JW
    Front Mol Neurosci; 2018; 11():89. PubMed ID: 29628874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epilepsy-Related Protein PCDH19 Regulates Tonic Inhibition, GABA
    Serratto GM; Pizzi E; Murru L; Mazzoleni S; Pelucchi S; Marcello E; Mazzanti M; Passafaro M; Bassani S
    Mol Neurobiol; 2020 Dec; 57(12):5336-5351. PubMed ID: 32880860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of extra-synaptic α5-GABA
    Etherington LA; Mihalik B; Pálvölgyi A; Ling I; Pallagi K; Kertész S; Varga P; Gunn BG; Brown AR; Livesey MR; Monteiro O; Belelli D; Barkóczy J; Spedding M; Gacsályi I; Antoni FA; Lambert JJ
    Neuropharmacology; 2017 Oct; 125():353-364. PubMed ID: 28807671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Functional Alterations and Therapeutic Options of Two Pathological De Novo Variants of the T292 Residue of GABRA1 Identified in Children with Epileptic Encephalopathy and Neurodevelopmental Disorders.
    Chen W; Ge Y; Lu J; Melo J; So YW; Juneja R; Liu L; Wang YT
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered cortical GABAA receptor composition, physiology, and endocytosis in a mouse model of a human genetic absence epilepsy syndrome.
    Zhou C; Huang Z; Ding L; Deel ME; Arain FM; Murray CR; Patel RS; Flanagan CD; Gallagher MJ
    J Biol Chem; 2013 Jul; 288(29):21458-21472. PubMed ID: 23744069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic clustering differences due to different GABRB3 mutations cause variable epilepsy syndromes.
    Shi YW; Zhang Q; Cai K; Poliquin S; Shen W; Winters N; Yi YH; Wang J; Hu N; Macdonald RL; Liao WP; Kang JQ
    Brain; 2019 Oct; 142(10):3028-3044. PubMed ID: 31435640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of nonsense mutation in GABRG2 with abnormal trafficking of GABAA receptors in severe epilepsy.
    Ishii A; Kanaumi T; Sohda M; Misumi Y; Zhang B; Kakinuma N; Haga Y; Watanabe K; Takeda S; Okada M; Ueno S; Kaneko S; Takashima S; Hirose S
    Epilepsy Res; 2014 Mar; 108(3):420-32. PubMed ID: 24480790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-type Calcium Channel Blockers Enhance Trafficking and Function of Epilepsy-associated α1(D219N) Subunits of GABA(A) Receptors.
    Han DY; Guan BJ; Wang YJ; Hatzoglou M; Mu TW
    ACS Chem Biol; 2015 Sep; 10(9):2135-48. PubMed ID: 26168288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous GABAA receptor subunit expression in pediatric epilepsy patients.
    Porter BE; Zhang G; Celix J; Hsu FC; Raol YH; Telfeian A; Gallagher PR; Coulter DA; Brooks-Kayal AR
    Neurobiol Dis; 2005 Apr; 18(3):484-91. PubMed ID: 15755675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABAA receptor-mediated IPSCs and alpha1 subunit expression are not reduced in the substantia nigra pars reticulata of gerbils with inherited epilepsy.
    Kumar SS; Wen X; Yang Y; Buckmaster PS
    J Neurophysiol; 2006 Apr; 95(4):2446-55. PubMed ID: 16407426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional genomics of epilepsy-associated mutations in the GABA
    Absalom NL; Ahring PK; Liao VW; Balle T; Jiang T; Anderson LL; Arnold JC; McGregor IS; Bowen MT; Chebib M
    J Biol Chem; 2019 Apr; 294(15):6157-6171. PubMed ID: 30728247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term effects of recurrent seizures in neonate period on gamma-aminobutyric acid A receptor alpha1 and beta2 subunits expression in adult brain: experiment with rats].
    Bo T; Chen Y; Mao DA; Zhu XH; Li YF
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):275-8. PubMed ID: 17425879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three brief epileptic seizures reduce inhibitory synaptic currents, GABA(A) currents, and GABA(A)-receptor subunits.
    Evans MS; Cady CJ; Disney KE; Yang L; Laguardia JJ
    Epilepsia; 2006 Oct; 47(10):1655-64. PubMed ID: 17054688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA
    Ordaz RP; Garay E; Limon A; Pérez-Samartín A; Sánchez-Gómez MV; Robles-Martínez L; Cisneros-Mejorado A; Matute C; Arellano RO
    Mol Pharmacol; 2021 Feb; 99(2):133-146. PubMed ID: 33288547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.